![Patrick Heron](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrick Heron
Directeur/Membre du Conseil chez
ARCUTIS BIOTHERAPEUTICS, INC.
Fortune : 2 M $ au 31/05/2026
Profil
Patrick J.
Heron was the founder of QuatRx Pharmaceuticals Co., founded in 2000, where the title held was Director from 2012 to 2017.
Current jobs include Director at VentiRx Pharmaceuticals, Inc., Alpha-9 Oncology, Inc., Bluewater Biosciences, Inc., Zavante Therapeutics, Inc., Iterum Therapeutics International Ltd., and Iterum Therapeutics US Holding Ltd. Independent Director at Mirum Pharmaceuticals, Inc. since 2018, Independent Director at Arcutis Biotherapeutics, Inc. since 2016, Lead Independent Director at MBX Biosciences, Inc. since 2020, Member-Managers Board at Calibrium LLC, and Managing Partner at Frazier Management LLC since 1999.
Former jobs include Chairman at Kalidex Pharmaceuticals, Inc. (2012–2013) and Scout Bio, Inc. (2018–2023); Director roles at Panomics LLC, Chimerix, Inc., Avera Pharmaceuticals, Inc., Informed Medical Communications, Inc., PreCision Dermatology, Inc., Tobira Therapeutics, Inc., Moximed, Inc., Ignyta, Inc., ARMO Biosciences, Inc., Amunix, Inc., and Recida Therapeutics, Inc.; Director at Emergent Product Development Seattle (2002–2010), Collegium Pharmaceutical, Inc. (2008–2016), Cerexa, Inc. (2005–2007), Marcadia Biotech, Inc. (2006–2010), Calixa Therapeutics, Inc. (2007–2009), Silvergate Pharmaceuticals, Inc. (2011–2019), MedPointe, Inc. (2001–2007), Cidara Therapeutics, Inc. (2014–2015), Imago BioSciences, Inc. (2014–2022), Tobira Therapeutics, Inc. (2015–2016), Vaxcyte, Inc. (2017–2021), Iterum Therapeutics Plc (2015–2021), Passage Bio, Inc. (2018–2021), HilleVax, Inc. (2020–2025), SanReno Therapeutics (2022–2023); Engagement Manager at McKinsey & Co., Inc. in 1999; Principal at The General Hospital Corp.
and Cetus Corp.
Education includes an MBA degree from Harvard Business School, conferred in 1996.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 05/06/2026 | 32 213 ( 0,03 % ) | 691 291 $ | 31/05/2026 | |
| 17/02/2026 | 5 703 ( 0,01 % ) | 578 855 $ | 31/05/2026 | |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company 0,03 % | 31/01/2025 | 9 110 ( 0,03 % ) | 507 154 $ | 31/05/2026 |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders 0,02 % | 01/11/2025 | 14 937 ( 0,02 % ) | 143 246 $ | 31/05/2026 |
| 04/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Patrick Heron
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| MIRUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 07/11/2018 |
| MBX BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/07/2020 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 01/08/1999 |
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals and diabetic drugs | Directeur/Membre du Conseil | - |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Directeur/Membre du Conseil | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Directeur/Membre du Conseil | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Directeur/Membre du Conseil | - |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Directeur/Membre du Conseil | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Patrick Heron
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Patrick Heron
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
76
Relations au 1er degré
45
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 45 |
|---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Manufactures and develops therapeutic compounds | Health Technology |
Panomics LLC
 Panomics LLC Miscellaneous Commercial ServicesCommercial Services Provides life sciences research reagents | Commercial Services |
Chimerix, Inc.
 Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Avera Pharmaceuticals, Inc.
 Avera Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops drugs and therapies | Health Services |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical products | Health Technology |
Informed Medical Communications, Inc.
 Informed Medical Communications, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical forums, training services, and integrated medical communications | Commercial Services |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Cerexa, Inc.
 Cerexa, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
VentiRx Pharmaceuticals, Inc.
 VentiRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines | Health Technology |
Marcadia Biotech, Inc.
 Marcadia Biotech, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for diabetes and obesity | Health Technology |
Calixa Therapeutics, Inc.
 Calixa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes hospital-based anti-infective therapies | Health Technology |
Kalidex Pharmaceuticals, Inc.
 Kalidex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops antibiotics for the treatment of serious infections | Health Technology |
PreCision Dermatology, Inc.
 PreCision Dermatology, Inc. Pharmaceuticals: MajorHealth Technology Develops skincare therapies | Health Technology |
Silvergate Pharmaceuticals, Inc.
 Silvergate Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals and diabetic drugs | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets, and sells therapeutics | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Cetus Corp.
 Cetus Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc. /Old/
 Tobira Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company, which develops and commercializes antiviral products | Health Technology |
Amunix, Inc.
 Amunix, Inc. Pharmaceuticals: MajorHealth Technology Develops protein pharmaceuticals | Health Technology |
Moximed, Inc.
 Moximed, Inc. Medical SpecialtiesHealth Technology Develops medical device treatments | Health Technology |
Ignyta, Inc.
 Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Imago BioSciences, Inc.
 Imago BioSciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicines for the treatment of myeloproliferative neoplasms and bone marrow diseases | Health Technology |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical products | Health Technology |
Scout Bio, Inc.
 Scout Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that specializes in veterinary, animal health and gene therapy | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Recida Therapeutics, Inc.
 Recida Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development of novel therapeutics | Health Technology |
Arcutis Biotherapeutics, Inc.
 Arcutis Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunodermatology drug development company | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
Sanreno Therapeutics
 Sanreno Therapeutics BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the discovery, development and commercialization of therapies for kidney diseases | Health Technology |
Bluewater Biosciences, Inc.
 Bluewater Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel platform for unimolecular multi-target medicines | Commercial Services |
